These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 109213)

  • 1. [Criteria of resistance of some antibiotics and chemotherapeutics for strains of Mycobacterium tuberculosis isolated in Czechoslovakia. Cycloserin, ethionamide, pyrazinamide, rifampicin, and ethambutol (author's transl)].
    Víznerová A
    Cas Lek Cesk; 1979 Feb; 118(8):240-5. PubMed ID: 109213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitivity of m. kansasii strains to various antibiotics and chemotherapeutics in vitro and in vivo (author's transl)].
    Burjanová B; Dornetzhuber V
    Z Erkr Atmungsorgane; 1975 Jan; 142(1):68-77. PubMed ID: 58490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction of L-forms of Mycobacterium tuberculosis under the action of ethambutol, ethionamide and their combinations with some antibiotic and tuberculostatic drugs].
    Dorozhkova IR; Volk AV
    Antibiotiki; 1973 Feb; 18(2):144-8. PubMed ID: 4130173
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract]   [Full Text] [Related]  

  • 9. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J; Wallace A
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of radiation on microbiologic characteristics of M tuberculosis.
    Zack MB; Stottmeier K; Berg G; Kazemi H
    Chest; 1974 Sep; 66(3):240-3. PubMed ID: 4213816
    [No Abstract]   [Full Text] [Related]  

  • 11. Experiences of the cycloserine sensitivity tests performed at the second chemotherapy trial of the IUAT.
    Lind A
    Scand J Respir Dis Suppl; 1970; 71():279-84. PubMed ID: 4989518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
    Ibarra JP; Piñeyro J; Trenchi A; Tarallo NH; Lanne de Farriols ME; Cuñarro de Gimeno G; Fernández Latorre I
    Hoja Tisiol; 1967; 24(1):5-88. PubMed ID: 4308762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 14. [Present state of resistance to antibiotics by tuberculous bacilli in Africa (author's transl)].
    Rey JL; Villon A; Menard M; Le Mao G; Albert JP
    Med Trop (Mars); 1979; 39(2):149-54. PubMed ID: 91079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dihydrostreptomycin as a factor inducing L-forms in Mycobacterium tuberculosis].
    Dorozhkova IR; Volk AV
    Antibiotiki; 1972 Oct; 17(10):915-22. PubMed ID: 4121154
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phases of morphogenesis of L forms of Mycobacterium tuberculosis, developing on exposure to antibiotics and tuberculostatic agents].
    Dorozhkova IR; Volk AV
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Nov; 50(11):12-8. PubMed ID: 4131407
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological criteria of rifampicin and ethambutol resistance].
    Afanasieva JP
    G Ital Chemioter; 1972; 19(2):16-9. PubMed ID: 4199028
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.